Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

Also called NCT07740330

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Clinique Saint-Luc (from the registry)
Registry
  • NCT NCT07740330
  • EU CT 2026-526581-24-01
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07740330. Randomized; quadruple masking; primary purpose prevention. Start 2026-10 (anticipated); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery
Acronym
TRANSCAB
Condition
Perioperative Bleeding
Intervention (Drug)
Oral tranexamic acid
Intervention (Drug)
Exacyl®
Intervention (Drug)
Intravenous placebo
Lead sponsor
Clinique Saint-Luc (class: research network)

Record details

Record id
cardio:ct-nct07740330
Content hash
2519c4c29e4927575b65025ce948a6b190fef58a89d805acbff79738774b055f